Skip to main content

Ocular Therapeutix, Inc

OCUL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001393434

In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.

13F holders, Q1 2023

Institutional positions in Ocular Therapeutix, Inc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
127
+11 vs. Q4 2022
Shares held
40.5M
+874.2K (+2.2%) vs. Q4 2022
Total value
$213.8M
+$102.5M (+92.1%) vs. Q4 2022
New holders
27
39 more added
Sold out
16
33 more reduced

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting OCUL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 127 institutions
Q1 2021: 154 institutionsQ2 2021: 149 institutionsQ3 2021: 141 institutionsQ4 2021: 140 institutionsQ1 2022: 132 institutionsQ2 2022: 123 institutionsQ3 2022: 130 institutionsQ4 2022: 116 institutionsQ1 2023: 127 institutionsQ2 2023: 135 institutionsQ3 2023: 114 institutionsQ4 2023: 119 institutionsQ1 2024: 147 institutionsQ2 2024: 151 institutionsQ3 2024: 168 institutionsQ4 2024: 180 institutionsQ1 2025: 197 institutionsQ2 2025: 187 institutionsQ3 2025: 216 institutionsQ4 2025: 249 institutionsQ1 2026: 271 institutionsQ2 2026: 262 institutions
Value heldQ1 2023: $213.8M
Q1 2021: $774.9MQ2 2021: $685.8MQ3 2021: $445.7MQ4 2021: $289.1MQ1 2022: $215.4MQ2 2022: $178.2MQ3 2022: $177.6MQ4 2022: $111.3MQ1 2023: $213.8MQ2 2023: $224.2MQ3 2023: $127.0MQ4 2023: $328.8MQ1 2024: $1.12BQ2 2024: $939.8MQ3 2024: $1.22BQ4 2024: $1.14BQ1 2025: $1.01BQ2 2025: $1.45BQ3 2025: $2.20BQ4 2025: $2.33BQ1 2026: $1.77BQ2 2026: $2.03B
Institutions holding OCUL and their total value by quarter
QuarterHoldersValue
Q2 2026262$2.03B
Q1 2026271$1.77B
Q4 2025249$2.33B
Q3 2025216$2.20B
Q2 2025187$1.45B
Q1 2025197$1.01B
Q4 2024180$1.14B
Q3 2024168$1.22B
Q2 2024151$939.8M
Q1 2024147$1.12B
Q4 2023119$328.8M
Q3 2023114$127.0M
Q2 2023135$224.2M
Q1 2023127$213.8M
Q4 2022116$111.3M
Q3 2022130$177.6M
Q2 2022123$178.2M
Q1 2022132$215.4M
Q4 2021140$289.1M
Q3 2021141$445.7M
Q2 2021149$685.8M
Q1 2021154$774.9M

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Ocular Therapeutix, Inc; share changes are against Q4 2022.

Institutions holding OCUL in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Charles Schwab Investment Management Inc206,249$1.09M0.00%+1,720+0.8%Added
Levin Capital Strategies, L.P.207,624$1.09M0.14%−63,068−23.3%Reduced
EAM Investors, LLC224,211$1.18M0.23%+224,211New
Susquehanna International Group, LLP244,579$1.29M0.00%+112,283+84.9%Added
Banco Santander, S.A.267,889$1.41M0.02%−60,425−18.4%Reduced
Barclays PLC279,687$1.47M0.00%−39,147−12.3%Reduced
Knoll Capital Management, LLC200,000$1.50M2.51%+200,000New
Bank of New York Mellon Corp290,055$1.53M0.00%+23,699+8.9%Added
Wellington Management Group LLP307,108$1.62M0.00%−6,084−1.9%Reduced
Two Sigma Advisers, LP309,400$1.63M0.00%−12,300−3.8%Reduced
Two Sigma Investments, LP323,424$1.70M0.01%+134,339+71.0%Added
UBS Oconnor LLC363,286$1.91M0.05%+363,286New
Norges Bank494,300$2.60M0.00%+494,300New
Endurant Capital Management LP512,744$2.70M1.39%−551,209−51.8%Reduced
Cetera Investment Advisers601,150$3.17M0.03%+5,950+1.0%Added
Northern Trust Corp657,097$3.46M0.00%+1,441+0.2%Added
Millennium Management LLC1,036,555$5.46M0.01%+959,233+1,240.6%Added
D. E. Shaw & Co., Inc.1,099,770$5.80M0.01%+131,436+13.6%Added
Morgan Stanley1,181,703$6.23M0.00%+753,831+176.2%Added
Geode Capital Management, LLC1,457,740$7.68M0.00%+47,087+3.3%Added
State Street Corp1,492,959$7.87M0.00%+105,627+7.6%Added
Citadel Advisors LLC1,526,272$8.04M0.01%−421,464−21.6%Reduced
Deltec Asset Management LLC1,913,612$10.1M2.49%+60,667+3.3%Added
Vanguard Group Inc4,041,390$21.3M0.00%+64,537+1.6%Added
BlackRock Inc.4,918,309$25.9M0.00%−34,428−0.7%Reduced
Opaleye Management Inc.6,105,900$32.2M9.64%+30,900+0.5%Added
Summer Road LLC6,122,089$32.3M100.00%00.0%Unchanged
Emerald Mutual Fund Advisers Trust0$00.00%−680,588−100.0%Sold out
XTX Topco Ltd0$00.00%−236,851−100.0%Sold out
State of Wisconsin Investment Board0$00.00%−105,800−100.0%Sold out
Panagora Asset Management Inc0$00.00%−38,757−100.0%Sold out
CSS LLC0$00.00%−25,809−100.0%Sold out
Caption Management, LLC0$00.00%−25,000−100.0%Sold out
Verition Fund Management LLC0$00.00%−17,502−100.0%Sold out
Dynamic Technology Lab Private Ltd0$00.00%−15,814−100.0%Sold out
Russell Investments Group, Ltd.0$00.00%−13,561−100.0%Sold out
HSBC Holdings PLC0$00.00%−11,940−100.0%Sold out
Centerpoint Advisors, LLC0$00.00%−3,390−100.0%Sold out
IFP Advisors, Inc0$00.00%−1,000−100.0%Sold out
Money Concepts Capital Corp0$00.00%−1,000−100.0%Sold out
Quent Capital, LLC0$00.00%−490−100.0%Sold out
Credit Suisse AG0$00.00%−3−100.0%Sold out
Sofos Investments, Inc.0$00.00%−3−100.0%Sold out